Revolutionizing Treatment for Neurodegenerative Diseases with Clene's CNM-Au8

Update: 2024-08-30

Description

In this episode, we discuss Clene, a biopharmaceutical company making strides in treating neurodegenerative diseases like ALS and MS with their oral nanotherapeutic, CNM-Au8. CEO Rob Etherington shares trial results showing promise in increasing survival rates and improving outcomes for ALS patients, as well as enhancing vision, cognition, and neural function in MS. Clene's focus on mitochondrial health and neuron function is highlighted in the discussion.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Innovations in Healthcare: AI-Pathology Integration, Lab Ordering Revolution, and mHealth App Launch

2024-11-1909:05

Innovations in Healthcare Funding, Drug Discovery, and Safety Measures

2024-10-0308:14

Healthcare Innovations and Industry Updates: Clene's Offerings, Stroke Hero Awards, Telemedicine Launch, and More

2024-10-0113:44

Innovative Medication Timing Cap and Transformational Journey at The Unbroken Men Challenge

2024-09-2602:56

Wellness Innovations, FDA Discussions, and Cardiovascular Health Initiatives

2024-09-2613:14

Insights on Assisted Living, Bullying, Healthcare Disparities, Neurodegenerative Disease Treatment, Cancer Innovation, AI Technology, and Comprehensive Dental Care

2024-09-1311:23

Cardiovascular Health in Pregnancy and Innovations in Pain Therapeutics

2024-09-0803:10

Healthcare Innovations and Trends in Today's Episode

2024-09-0515:33

Healthcare Innovations and Partnerships: Digital Front Door, NFL PLAY 60, PAD Collaborative, and PathAI

2024-09-0411:09

Exploring Diversification in Healthcare with the XLV Fund

2024-09-0202:10

Revolutionizing Treatment for Neurodegenerative Diseases with Clene's CNM-Au8

2024-08-3001:55

Advancements in Biopharmaceuticals, Cancer Screening Diagnostics, and Hydrological Science

2024-08-2304:22

Innovations in Healthcare Technology, Biotech Breakthroughs, and Revolutionary Permanent Makeup Services

2024-08-2105:32

Health Innovations and Industry Updates: UNOS Chief Medical Officer, LogicMark's Aster App, 1935 CBD's Chiropractic Options, and More

2024-08-2008:43

Growth of Sports Market and Successful Renewable Energy Project in Kenya

2024-08-1703:06

Consensus Health Wins Bronze Stevie® Award for Excellence in Healthcare

2024-08-1501:59

Innovations in Healthcare: Oral Hygiene, Integrative Medicine, and Deaf Patient Care

2024-08-1504:08

Health-Tech Innovations, Immunotherapy Breakthroughs, and Executive Compensation Analysis

2024-08-1405:04

Enhancing Pathology with AI: PathAI Launches AIM-MASH on AISight System

2024-08-1302:09

Innovative Products and Partnerships: Safety Shot, XpertDox, and Resonance Sports Acupuncture

2024-08-1304:01

00:00

Revolutionizing Treatment for Neurodegenerative Diseases with Clene's CNM-Au8

#box-pro-ellipsis-173220934204475{-webkit-line-clamp:2;}Revolutionizing Treatment for Neurodegenerative Diseases with Clene's CNM-Au8

Revolutionizing Treatment for Neurodegenerative Diseases with Clene's CNM-Au8

NewsRamp

Revolutionizing Treatment for Neurodegenerative Diseases with Clene's CNM-Au8